Notiek ielāde

Slzii.com Meklēt

Meklēt (Jaunumi)

AstraZeneca Liver Cancer Regimen Extends Progression-Free Survival in Phase III Trial

AstraZeneca Liver Cancer Regimen Extends Progression-Free Survival in Phase III Trial
Mychesco english world

WILMINGTON, DE — AstraZeneca (LSE/STO/NYSE: AZN) reported Phase III trial results showing that a combination of its immunotherapy drugs IMFINZI and IMJUDO with lenvatinib and transarterial chemoembolization (TACE) significantly delayed ...
2026-06-11 23:00:00

ko tu dari?
0.12849092483521


Jaunumi
Jaunumi

Jaunākās ziņas un virsraksti
WILMINGTON, DE — AstraZeneca (LSE/STO/NYSE: AZN) reported Phase III trial results showing that a combination of its immunotherapy drugs IMFI...
Jaunumi